Literature DB >> 11165930

Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae.

E Charpentier1, E Tuomanen.   

Abstract

Streptococcus pneumoniae is a major pathogen causing potentially life-threatening community-acquired diseases in both the developed and developing world. Since 1967, there has been a dramatic increase in the incidence of penicillin-resistant and multiply antibiotic-resistant pneumococci worldwide. Prevention of access of the antibiotic to the target, inactivation of the antibiotic and alteration of the target are mechanisms that S. pneumoniae has developed to resist antibiotics. Recent studies on antibiotic-tolerant pneumococcal mutants permitted development of a novel model for the control of bacterial cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11165930     DOI: 10.1016/s1286-4579(00)01345-9

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  17 in total

1.  Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.

Authors:  Ingrid Bourgeois; Martine Pestel-Caron; Jean-Francois Lemeland; Jean-Louis Pons; Francois Caron
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Molecular analysis of pbp2b in Streptococcus pneumonia isolated from clinical and normal flora samples.

Authors:  J Sadeghi; A Ahamadi; M Douraghi; M R Pourshafie; M Talebi
Journal:  Curr Microbiol       Date:  2014-10-02       Impact factor: 2.188

3.  Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence.

Authors:  Ernesto J Muñoz-Elías; John D McKinney
Journal:  Nat Med       Date:  2005-05-15       Impact factor: 53.440

4.  Transcriptional regulation in the Streptococcus pneumoniae rlrA pathogenicity islet by RlrA.

Authors:  David L Hava; Carolyn J Hemsley; Andrew Camilli
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

5.  SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model.

Authors:  Gili Regev-Yochay; Krzysztof Trzcinski; Claudette M Thompson; Marc Lipsitch; Richard Malley
Journal:  J Bacteriol       Date:  2007-07-13       Impact factor: 3.490

6.  Genotypes and serotype distribution of macrolide resistant invasive and non-invasive Streptococcus pneumoniae isolates from Lebanon.

Authors:  Nedal Taha; George F Araj; Rima H Wakim; Souha S Kanj; Zeina A Kanafani; Ahmad Sabra; Marie-Therese Khairallah; Farah J Nassar; Marwa Shehab; Maysa Baroud; Ghassan Dbaibo; Ghassan M Matar
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-01-16       Impact factor: 3.944

7.  Nasopharyngeal Carriage Rate and Serotypes of Streptococcus pneumoniae and Antimicrobial Susceptibility in Healthy Korean Children Younger than 5 Years Old: Focus on Influence of Pneumococcal Conjugate Vaccination.

Authors:  Eu Kyoung Lee; Ja Kyung Jun; Ui Yoon Choi; Hyo-Jin Kwon; Kyung-Hyo Kim; Jin Han Kang
Journal:  Infect Chemother       Date:  2013-03-29

8.  The pseudomonas quinolone signal (PQS) balances life and death in Pseudomonas aeruginosa populations.

Authors:  Susanne Häussler; Tanja Becker
Journal:  PLoS Pathog       Date:  2008-09-26       Impact factor: 6.823

9.  Antimicrobial drug use and resistance in Europe.

Authors:  Nienke van de Sande-Bruinsma; Hajo Grundmann; Didier Verloo; Edine Tiemersma; Jos Monen; Herman Goossens; Matus Ferech
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

10.  Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance.

Authors:  Regina Joice; Marc Lipsitch
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.